A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Robinson, M.D.
Ethicon, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Allgemeines Krankenhaus, Abteilung Für Gynäkologie Und Geburtshilfe
Linz, Austria
- Frauenklinik, Universitatsklinikum Erlangen
Erlangen, Germany
- Vrije Universiteit Medisch Centrum (vu Medical Center), Dept of Obstetrics and Gynaecology
Amsterdam, Netherlands
- Ullevaal University Hospital, Department of Obstetrics & Gynaecology
Oslo, Norway
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2010
- Primary completion
- 30 Jun 2010
- Completion
- 31 Jul 2010
- Last update posted
- 17 Feb 2011
- Registered enrollment
- 2
- Registry id
- NCT01140555
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.